Concepedia

Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment

Ian McGowan, Charlene S. Dezzutti, Aaron Siegel, Jarret Engstrom, Alexiy Nikiforov, Kathryn Duffill, Cory Shetler, Nicola Richardson‐Harman, Kaleab Z. Abebe, David Back,

The Lancet HIV · 2016 · 76 citations · 14 references

DOI

Concepts

References

14

Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

Xiping Wei, Julie M. Decker, Hongmei Liu et al. · Antimicrobial Agents and Chemotherapy · 2002 · 1.6K citations · Full text

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Hilde Azijn, Ilse Tirry, Johan Vingerhoets et al. · Antimicrobial Agents and Chemotherapy · 2009 · 291 citations · Full text

, , +15

Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue

Peter A. Anton, Julie Elliott, Michael A. Poles et al. · AIDS · 2000 · 176 citations

Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis

Manjula Gunawardana, Mariana Remedios-Chan, Christine S. Miller et al. · Antimicrobial Agents and Chemotherapy · 2015 · 162 citations · Full text

RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate

Peter A. Anton, Ross Cranston, Angela D. M. Kashuba et al. · AIDS Research and Human Retroviruses · 2012 · 135 citations · Full text

, , +20